CClinicalTrials.gg
CompletedNCT02442934IPREA3Updated Mar 21, 2016

Reducing Discomforts in Critically Ill Patients: the IPREA3 Study

An interventional study of Administration of the IPREA3 questionnaire and Immediate feedback through electronic reminder messages in Critical Illness, sponsored by Dr Pierre KALFON. Completed at 26 sites in France. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2016-03-21.

Sponsored by Dr Pierre KALFON · Not applicable, Interventional, and Supportive care

Phase
Not applicable
Study type
Interventional
Enrollment
5,411
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

Since critically ill patients are exposed to stressful conditions, the investigators evaluated the effectiveness of a multicomponent program to reduce perceived discomforts in the Intensive Care Unit (ICU) .

Read the detailed description

The investigators conducted a cluster-randomized trial randomizing 34 ICUs. The program targeted staff members with 3 components : web-based systematic measurement of discomforts on the day of ICU discharge by institutional caregivers (nurses and assistant nurses of the participating ICU), immediate feedback through electronic reminder messages intended to caregivers, and targeted interventions in each ICU based on comparative discomfort scores monthly reported to local champions who were also responsible for staff education.

The measurement of discomforts perceived by critically ill patients at the end of the ICU stay, related to the whole stay in the ICU, was performed by the bedside nurse using a specific questionnaire, the IPREA questionnaire whose construct validity, external validity, reliability, reproducibility and acceptability have been already demonstrated (Development and validation of a questionnaire for quantitative assessment of perceived discomforts in critically ill patients. Kalfon P et al, Intensive care Med 2010, 36:1751-58). The version of the IPREA questionnaire used in the study was a 18-item questionnaire : noise ; excessive light ; discomfort related to sleeping in a different bed from home ; sleep deprivation ; thirst ; hunger ; feeling of cold ; feeling of heat ; pain ; being tied down by perfusion lines, tubes or as a result of connections due to monitoring devices ; no respect for intimacy ; anxiety ; isolation ; limited visiting hours ; absence of phone ; lack of information ; shortness of breath ; and depression.

The duration of the program is 6 months in each arm. Potential participants in the study were consecutive patients admitted in all the participating ICU that are divided in two groups of 17 ICUs.

During October 2014, the IPREA questionnaire is administered to all potentially eligible patients hospitalized in the 34 participating ICUs without applying the program (period P1). The 17 ICUs of the group 1 do not apply the multicomponent program during 5 months (until March 2015), while the 17 ICUs of the group 2 apply the program (period P2). During April 2015, the questionnaire IPREA is administered again in both groups (period P3). From May 2015 until September 2015, the multicomponent program is only applied in the group 1 and no longer in the group 2 (period P4) in order to achieve the crossover of the intervention. During October 2015, the questionnaire IPREA is administered again in both groups (period P5).

The overall score of discomfort and the scores for each item will be compared in the control arm and in the interventional arm.

The control arm consists in the patients included in the group 2 during October 2014 and the patients included in the group 1 during April 2015, i.e. patients included during the month preceding the implementation of the multicomponent program.

The interventional arm consists in the patients included in the group 2 during April 2015 and the patients included in the group 1 during October 2015, i.e. patients included during the last month of the period of application of the multicomponent program.

02

Conditions studied

  • Critical Illness

Browse trials for

Keywords

  • Critical Care
  • Critical Care Nursing
  • Discomfort
  • Sleep deprivation
  • Noise
  • Thirst
  • Pain
03

In context

Critical Illness

1,881 studies on the registry are indexed under Critical Illness; 462 are open to participants now.

This study's enrollment of 5,411 is above the median of 90 across 979 interventional studies indexed under Critical Illness.

Browse Critical Illness studies →

Lead sponsor

This is the only study on the registry with Dr Pierre KALFON as lead sponsor.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • adult critically ill patients
  • ICU stay of three calendar days or more

Exclusion criteria

Exclusion Criteria:

  • deceased patient in the ICU
  • ICU stay of two calendar days or less
  • patient younger than 18
  • patient under trusteeship
  • patient refusing to participate to the study
  • patient with diminished mental capacity
  • patient not understanding French sufficiently to be questioned (language barrier)
  • transfer to another ICU while mechanically ventilated
  • emergency discharge
05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Crossover assignment
Masking
Single (Participant)
Enrollment
5,411 participants (actual)

Study arms

  • Experimental
    Multicomponent program

    Multicomponent intervention to reduce perceived discomforts in critically ill patients : the IPREA3 program

    Other: Administration of the IPREA3 questionnaire · Other: Immediate feedback through electronic reminder messages · Other: Targeted interventions in each ICU to reduce discomforts

  • Active comparator
    Standard Care

    Standard care

    Other: Administration of the IPREA3 questionnaire

Interventions

  • OtherAdministration of the IPREA3 questionnaire

    On the day of the ICU discharge, the bedside nurse administers to the patient the 18-item IPREA questionnaire i.e the nurse asks the patient to rate the severity of each discomfort source contained in the IPREA3 questionnaire experienced during the entire stay in the ICU

  • OtherImmediate feedback through electronic reminder messages

    After the nurse had administered the questionnaire, warning messages are displayed on the screen corresponding to the key points to prevent the three discomforts reported with the highest scores

  • OtherTargeted interventions in each ICU to reduce discomforts

    These targeted interventions are implemented through the coordination of two local champions. The central coordination IPREA3 team sends each month to the local champions monthly and cumulative discomfort scores of their unit (overall score of discomfort and scores for each item) and their ranking relative to other units assigned to the interventional arm i.e applying the IPREA3 program. The local champions organize monthly meetings with the unit staff to present the results in terms of perceived discomforts measured by the IPREA questionnaire, identify main discomfort sources and actions to be conducted to reduce the discomforts reported with the highest scores in the unit and those that are most easily preventable, and assess the efficacy of already applied measures.

06

What researchers measure

Primary outcomes

  1. Overall score of discomfort

    Each discomfort-item is scored 0-10 (example 0 = no pain ; 10 = pain as bad as can be). For each individual, the overall score of discomfort is computed as the mean of the 18 scores reported for each discomfort-item multiplied by 10, yielding an overall score between 0 and 100.

    Time frame: 1 Day of discharge from the ICU

Secondary outcomes

  1. Scores reported for each discomfort-item

    Each of the 18 discomfort-items is scored 0-10 (example 0 = no thirst ; 10 = thirst as bad as can be).

    Time frame: 1 Day of discharge from the ICU

07

Study locations

26 sites
  • CH Auxerre
    Auxerre, 89000, France
  • Hôpital de la Cavale Blanche
    Brest, 29609, France
  • CH Louis Pasteur
    Chartres, 28018, France
  • CHU Beaujon APHP
    Clichy, 92110, France
  • CHU Hôpital Bocage
    Dijon, 21079, France
  • CH Douai
    Douai, 59507, France
  • CHU Raymond Poincaré APHP
    Garches, 92380, France
  • CH La Rochelle
    La Rochelle, 17022, France
  • CH Le Puy en Velay
    Le Puy en Velay, 43000, France
  • CH Lens
    Lens, 62300, France
  • CHU Edouard Herriot
    Lyon, 69003, France
  • Hôpital Européen
    Marseille, 13003, France
  • CHU Hôpital Nord
    Marseille, 13005, France
  • Clinique Ambroise Paré
    Neuilly-sur-Seine, 92200, France
  • CHU Hôpital Pasteur2
    Nice, 06000, France
  • CHU Saint Louis APHP
    Paris, 75010, France
  • CHU La Pitié Salpétrière APHP
    Paris, 75013, France
  • CHU Cochin APHP
    Paris, 75014, France
  • Hôpital Saint Joseph
    Paris, 75014, France
  • CHU Hôpital Européen Georges Pompidou APHP
    Paris, 75015, France
  • CHU La Milétrie
    Poitiers, 86000, France
  • CH Victor Provo
    Roubaix, 59100, France
  • CHU NHC
    Strasbourg, 67000, France
  • CHU Hautepierre
    Strasbourg, 67100, France
  • Hôpital Saint Musse
    Toulon, 83100, France
  • CH Troyes
    Troyes, 10000, France
08

References and documents

Publications

  • Kalfon P, Mimoz O, Auquier P, Loundou A, Gauzit R, Lepape A, Laurens J, Garrigues B, Pottecher T, Malledant Y. Development and validation of a questionnaire for quantitative assessment of perceived discomforts in critically ill patients. Intensive Care Med. 2010 Oct;36(10):1751-1758. doi: 10.1007/s00134-010-1902-9. Epub 2010 May 26. PubMed 20502874 ↗
  • Kalfon P, Boucekine M, Estagnasie P, Geantot MA, Berric A, Simon G, Floccard B, Signouret T, Fromentin M, Nyunga M, Audibert J, Ben Salah A, Mauchien B, Sossou A, Venot M, Robert R, Follin A, Renault A, Garrouste-Orgeas M, Collange O, Levrat Q, Villard I, Thevenin D, Pottecher J, Patrigeon RG, Revel N, Vigne C, Azoulay E, Mimoz O, Auquier P, Baumstarck K; IPREA Study Group. Risk factors and events in the adult intensive care unit associated with pain as self-reported at the end of the intensive care unit stay. Crit Care. 2020 Dec 7;24(1):685. doi: 10.1186/s13054-020-03396-2. PubMed 33287910 ↗
  • Baumstarck K, Boucekine M, Estagnasie P, Geantot MA, Berric A, Simon G, Floccard B, Signouret T, Fromentin M, Nyunga M, Sossou A, Venot M, Robert R, Follin A, Audibert J, Renault A, Garrouste-Orgeas M, Collange O, Levrat Q, Villard I, Thevenin D, Pottecher J, Patrigeon RG, Revel N, Vigne C, Azoulay E, Mimoz O, Auquier P, Kalfon P; IPREA Study group. Assessment of patients' self-perceived intensive care unit discomforts: Validation of the 18-item version of the IPREA. Health Qual Life Outcomes. 2019 Feb 7;17(1):29. doi: 10.1186/s12955-019-1101-5. PubMed 30732654 ↗
  • Kalfon P, Baumstarck K, Estagnasie P, Geantot MA, Berric A, Simon G, Floccard B, Signouret T, Boucekine M, Fromentin M, Nyunga M, Sossou A, Venot M, Robert R, Follin A, Audibert J, Renault A, Garrouste-Orgeas M, Collange O, Levrat Q, Villard I, Thevenin D, Pottecher J, Patrigeon RG, Revel N, Vigne C, Azoulay E, Mimoz O, Auquier P; IPREA Study group. A tailored multicomponent program to reduce discomfort in critically ill patients: a cluster-randomized controlled trial. Intensive Care Med. 2017 Dec;43(12):1829-1840. doi: 10.1007/s00134-017-4991-x. Epub 2017 Nov 27. PubMed 29181557 ↗
  • Kalfon P, Mimoz O, Loundou A, Geantot MA, Revel N, Villard I, Amour J, Azoulay E, Garrouste-Orgeas M, Martin C, Sharshar T, Baumstarck K, Auquier P. Reduction of self-perceived discomforts in critically ill patients in French intensive care units: study protocol for a cluster-randomized controlled trial. Trials. 2016 Feb 16;17:87. doi: 10.1186/s13063-016-1211-x. PubMed 26880373 ↗

Individual participant data

Plan to share: Yes

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Mar 21, 2016, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT02442934
Lead sponsor
Dr Pierre KALFON
Responsible party
Dr Pierre KALFON (MD, PhD, Centre Hospitalier of Chartres) — Sponsor-investigator
First posted
May 13, 2015
Start date
Oct 2014
Primary completion
Oct 2015
Completion
Oct 2015
Last update
Mar 21, 2016

Study contacts

Pierre KALFON, MD, PhD
principal investigator · CH CHARTRES

Oversight

Data monitoring committee
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Mar 2016. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion